Analogy between temperature-dependent and concentration-dependent bacterial killing

Computers in Biology and Medicine

Volumn 32, Issue 6, 2002, Pages 529-549

  Neef, C ^a   Van Gils, S A ^b   IJzerman, W L ^b  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Aminoglycosides; Antibiotics; Ceftazidime; Ciprofloxacin; Lethality; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ANTIBIOTICS; AUTOCLAVES; PHARMACODYNAMICS; RATE CONSTANTS; STERILIZATION (CLEANING);

BACTERIAL KILLING;

BACTERIA;

CEFTAZIDIME; CIPROFLOXACIN; TOBRAMYCIN;

AREA UNDER THE CURVE; ARTICLE; AUTOCLAVE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; COMPUTER MODEL; CONCENTRATION RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG ELIMINATION; HALF LIFE TIME; INSTRUMENT STERILIZATION; LETHALITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE DEPENDENCE; VALIDATION PROCESS;

ANTI-BACTERIAL AGENTS; BACTERIOLYSIS; CEFTAZIDIME; CIPROFLOXACIN; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; STERILIZATION; TEMPERATURE; TIME FACTORS; TOBRAMYCIN;

BACTERIA (MICROORGANISMS);

EID: 0036843228     PISSN: 00104825     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-4825(02)00035-5     Document Type: Article

References (18)

1. Boom F.A., Paalman A.C.A. Microbiologische aspecten van het steriliseren van geneesmiddelen door hitte. Pharm. Weekbl. 114:1979;157-165.
2. Van Asten J., Dorpema J.W. A new approach to sterilization conditions, The IMO concept. Pharm. Weekbl. [Sci.]. 4:1982;49-56.
3. Craig W.A., Ebert S.C. Killing and regrowth of bacteria in vitro. a review Scand. J. Infect. Dis. Suppl. 74:1990;63-70.
4. Mattie H. A predictive parameter of antibacterial efficacy in vivo, based on efficacy in vitro and pharmacokinetics. Scand. J. Infect. Dis. Suppl. 74:1990;133-136.
5. Corvaisier S., Maire P.H., Bouvier d'Yvoire M.Y., Barbaut S., Bleyzac N., Jelliffe R.W. Comparisons between antimicrobial pharmacodynamic indices and bacterial killing as described by using the Zhi model. Antimicrob. Agents Chemother. 42:1998;1731-1737.
6. Firsov A.A., Vostrov S.N., Shevchenko A.A., Cornaglia G. Parameters of bacterial killing and regrowth kinetics and antimicrobial effect examined in terms of area under the concentration-time curve relationships. action of ciprofloxacin against Escherichia coli in an in vitro dynamic model Antimicrob. Agents Chemother. 41:1997;1281-1287.
7. Mattie H., van Dokkum A.M., Brus-Weijer L., Krul A.M., van Strijen E. Antibacterial activity of four cephalosporins in an experimental infection in relation to in vitro effect and pharmacokinetics. J. Infect. Dis. 162:1990;717-722.
8. Bouvier d'Yvoire M.J.Y., Maire P.H. Dosage regimens of antibacterials, implications of a pharmacokinetic/pharmacodynamic model. Clin. Drug Invest. 11:1996;229-239.
9. den Hollander J.G., Fuursted K., Verbrugh H.A., Mouton J.W. Duration and clinical relevance of postantibiotic effect in relation to the dosing interval. Antimicrob. Agents Chemother. 42:1998;749-754.
10. Drusano G.L. Human pharmacodynamics of beta-lactams, aminoglycosides and their combination. Scand. J. Infect. Dis. Suppl. 74:1990;235-248.
11. Drusano G.L., Craig W.A. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections. J. Chemother. 3(Suppl 9):1997;38-44.
12. Forrest A., Nix D.E., Ballow C.H., Goss T.F., Birmingham M.C., Schentag J.J. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients. Antimicrob. Agents Chemother. 37:1993;1073-1081.
13. Mouton J.W., van Ogtrop M.L., Andes D., Craig W.A. Use of pharmacodynamic indices to predict efficacy of combination therapy in vivo. Antimicrob. Agents Chemother. 43:1999;2473-2478.
14. Mouton J.W., Vinks A.A., Punt N.C. Pharmacokinetic-pharmacodynamic modeling of activity of ceftazidime during continuous and intermittent infusion. Antimicrob. Agents Chemother. 41:1997;733-738.
15. Chin N.X., Neu H.C. Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria. Am. J. Med. 82:1987;58-62.
16. den Hollander J.G., Mouton J.W., Verbrugh H.A. Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics. Antimicrob. Agents Chemother. 42:1998;744-748.
17. Firsov A.A., Vostrov S.N., Kononenko O.V., Zinner S.H., Portnoy Y.A. Prediction of the effects of inoculum size on the antimicrobial action of trovafloxacin and ciprofloxacin against Staphylococcus aureus and Escherichia coli in an in vitro dynamic model. Antimicrob. Agents Chemother. 43:1999;498-502.
18. Highet V.S., Forrest A., Ballow C.H., Schentag J.J. Antibiotic dosing issues in lower respiratory tract infection. population-derived area under inhibitory curve is predictive of efficacy J. Antimicrob. Chemother. 43(Suppl A):1999;55-63.